Boston Scientific Announces Results For Third Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
Boston Scientific (BSX) Tops Q3 EPS by 1c, Offers Q4 Guidance
October 23, 2019 6:38 AM EDTBoston Scientific (NYSE: BSX) reported Q3 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $2.71 billion versus the consensus estimate of $2.65 billion.
GUIDANCE:
Boston Scientific sees Q4 2019 EPS of $0.42-$0.45, versus the consensus of $0.44.
The company estimates revenue growth for the full year 2019, versus the prior year period, to be in a range of approximately 9 to 9.5 percent on a reported basis (compared... More
